These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38762089)

  • 1. Best practices for machine learning in antibody discovery and development.
    Wossnig L; Furtmann N; Buchanan A; Kumar S; Greiff V
    Drug Discov Today; 2024 Jul; 29(7):104025. PubMed ID: 38762089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning in Drug Discovery and Development Part 1: A Primer.
    Talevi A; Morales JF; Hather G; Podichetty JT; Kim S; Bloomingdale PC; Kim S; Burton J; Brown JD; Winterstein AG; Schmidt S; White JK; Conrado DJ
    CPT Pharmacometrics Syst Pharmacol; 2020 Mar; 9(3):129-142. PubMed ID: 31905263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning models for drug-target interactions: current knowledge and future directions.
    D'Souza S; Prema KV; Balaji S
    Drug Discov Today; 2020 Apr; 25(4):748-756. PubMed ID: 32171918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing graph machine learning within drug discovery and development.
    Gaudelet T; Day B; Jamasb AR; Soman J; Regep C; Liu G; Hayter JBR; Vickers R; Roberts C; Tang J; Roblin D; Blundell TL; Bronstein MM; Taylor-King JP
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Methods in Drug Discovery.
    Patel L; Shukla T; Huang X; Ussery DW; Wang S
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cheminformatics in Drug Discovery, an Industrial Perspective.
    Chen H; Kogej T; Engkvist O
    Mol Inform; 2018 Sep; 37(9-10):e1800041. PubMed ID: 29774657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of machine learning techniques to innovative antibacterial discovery and development.
    Serafim MSM; Kronenberger T; Oliveira PR; Poso A; Honório KM; Mota BEF; Maltarollo VG
    Expert Opin Drug Discov; 2020 Oct; 15(10):1165-1180. PubMed ID: 32552005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Big Data and Artificial Intelligence Modeling for Drug Discovery.
    Zhu H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.
    Terranova N; Venkatakrishnan K; Benincosa LJ
    AAPS J; 2021 May; 23(4):74. PubMed ID: 34008139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is one-shot learning a viable option in drug discovery?
    Baskin II
    Expert Opin Drug Discov; 2019 Jul; 14(7):601-603. PubMed ID: 30882252
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learnt from machine learning in early stages of drug discovery.
    Cavasotto CN; Di Filippo JI; Scardino V
    Expert Opin Drug Discov; 2024 Jun; 19(6):631-633. PubMed ID: 38727031
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
    Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
    SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
    Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
    Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets.
    Korotcov A; Tkachenko V; Russo DP; Ekins S
    Mol Pharm; 2017 Dec; 14(12):4462-4475. PubMed ID: 29096442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
    Zhang L; Tan J; Han D; Zhu H
    Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine.
    Paliwal A; Jain S; Kumar S; Wal P; Khandai M; Khandige PS; Sadananda V; Anwer MK; Gulati M; Behl T; Srivastava S
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):181-195. PubMed ID: 38480460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.